Literature DB >> 24452010

A hydrophobic residue in position 15 of the rP2X3 receptor slows desensitization and reveals properties beneficial for pharmacological analysis and high-throughput screening.

Ralf Hausmann1, Gregor Bahrenberg2, Daniel Kuhlmann3, Michaela Schumacher3, Ursula Braam3, Dagmar Bieler2, Ilka Schlusche2, Günther Schmalzing3.   

Abstract

The homotrimeric P2X3 subtype, one of the seven members of the ATP-gated P2X receptor family, plays a role in sensory neurotransmission, including nociception. To overcome the bias resulting from fast desensitization of the P2X3 receptor in dose-response analyses, a non-desensitizing P2X2-X3 receptor chimera has been repeatedly used as a surrogate for the P2X3 receptor for functional analysis. Here, we show that only three of the P2X2-specific amino acid residues of the P2X2-X3 chimera, (19)P(21)V(22)I, are needed to confer a slowly desensitizing phenotype to the P2X3 receptor. The strongest delay in desensitization of the P2X3 receptor by a single residue was observed when (15)Ser was replaced by Val or another hydrophobic residue. Pharmacologically, the S(15)V-rP2X3 mutant behaved similarly to the wt-P2X3 receptor. Analysis of the S(15)V-rP2X3 receptor in 1321N1 astrocytoma cells by a common calcium-imaging-based assay showed 10-fold higher calcium transients relative to those of the wt-rP2X3 receptor. The S(15)V-rP2X3 cell line enabled reliable analysis of antagonistic potencies and correctly reported the mechanism of action of the P2X3 receptor antagonists A-317491 and TNP-ATP by a calcium-imaging assay. Together, these data suggest that the S(15)V-rP2X3 mutant may be suitable not only for automated fluorescence-based screening of molecule libraries for identification of lead compounds but also for facilitated pharmacological characterization of specific P2X3 receptor ligands. We suggest that the mechanism of desensitization of the P2X3 receptor may involve the movement of an N-terminal inactivation particle, in analogy to the "hinged-lid" or "ball and chain" mechanisms of voltage-gated NaV and Shaker KV channels, respectively.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium imaging; Desensitization; Drug screening; Mechanism of antagonism; P2X3 receptor

Mesh:

Substances:

Year:  2014        PMID: 24452010     DOI: 10.1016/j.neuropharm.2014.01.010

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  13 in total

1.  The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors.

Authors:  Jeffrey S Wieskopf; Jayanti Mathur; Walrati Limapichat; Michael R Post; Mona Al-Qazzaz; Robert E Sorge; Loren J Martin; Dmitri V Zaykin; Shad B Smith; Kelen Freitas; Jean-Sebastien Austin; Feng Dai; Jie Zhang; Jaclyn Marcovitz; Alexander H Tuttle; Peter M Slepian; Sarah Clarke; Ryan M Drenan; Jeff Janes; Shakir Al Sharari; Samantha K Segall; Eske K Aasvang; Weike Lai; Reinhard Bittner; Christopher I Richards; Gary D Slade; Henrik Kehlet; John Walker; Uwe Maskos; Jean-Pierre Changeux; Marshall Devor; William Maixner; Luda Diatchenko; Inna Belfer; Dennis A Dougherty; Andrew I Su; Sarah C R Lummis; M Imad Damaj; Henry A Lester; Ardem Patapoutian; Jeffrey S Mogil
Journal:  Sci Transl Med       Date:  2015-05-13       Impact factor: 17.956

2.  Role of domain calcium in purinergic P2X2 receptor channel desensitization.

Authors:  Claudio Coddou; Zonghe Yan; Stanko S Stojilkovic
Journal:  Am J Physiol Cell Physiol       Date:  2015-02-11       Impact factor: 4.249

3.  How Structural Biology Has Directly Impacted Our Understanding of P2X Receptor Function and Gating.

Authors:  Steven E Mansoor
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Molecular Pharmacology of P2X Receptors: Exploring Druggable Domains Revealed by Structural Biology.

Authors:  Adam C Oken; Ipsita Krishnamurthy; Jonathan C Savage; Nicolas E Lisi; Michael H Godsey; Steven E Mansoor
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

5.  Subtype-specific mechanisms for functional interaction between α6β4* nicotinic acetylcholine receptors and P2X receptors.

Authors:  Walrati Limapichat; Dennis A Dougherty; Henry A Lester
Journal:  Mol Pharmacol       Date:  2014-06-25       Impact factor: 4.436

6.  Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization.

Authors:  Alanna E McCarthy; Craig Yoshioka; Steven E Mansoor
Journal:  Cell       Date:  2019-10-03       Impact factor: 41.582

7.  Inter-subunit disulfide locking of the human P2X3 receptor elucidates ectodomain movements associated with channel gating.

Authors:  Gabriele Stephan; Maria Kowalski-Jahn; Christopher Zens; Günther Schmalzing; Peter Illes; Ralf Hausmann
Journal:  Purinergic Signal       Date:  2016-01-29       Impact factor: 3.765

8.  X-ray structures define human P2X(3) receptor gating cycle and antagonist action.

Authors:  Steven E Mansoor; Wei Lü; Wout Oosterheert; Mrinal Shekhar; Emad Tajkhorshid; Eric Gouaux
Journal:  Nature       Date:  2016-09-14       Impact factor: 49.962

Review 9.  Key sites for P2X receptor function and multimerization: overview of mutagenesis studies on a structural basis.

Authors:  Ralf Hausmann; Achim Kless; Gunther Schmalzing
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

10.  Uncoupling sodium channel dimers restores the phenotype of a pain-linked Nav 1.7 channel mutation.

Authors:  Annika H Rühlmann; Jannis Körner; Ralf Hausmann; Nikolay Bebrivenski; Christian Neuhof; Silvia Detro-Dassen; Petra Hautvast; Carène A Benasolo; Jannis Meents; Jan-Philipp Machtens; Günther Schmalzing; Angelika Lampert
Journal:  Br J Pharmacol       Date:  2020-08-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.